Showing results (751-760 of 1,826) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|December 15, 2024
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancerMiao-Zhen Qiu, Yuxian Bai, Jufeng Wang, et al.
Signal Transduction and Targeted Therapy|January 12, 2025
A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancerZhiwei Chen, Jianhua Chen, Dingzhi Huang, et al.
Signal Transduction and Targeted Therapy|January 14, 2025
Digestive cancers: mechanisms, therapeutics and managementTianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy|February 7, 2025
Molecular mechanisms in liver repair and regeneration: from physiology to therapeuticsXiao Ma, Tengda Huang, Xiangzheng Chen, et al.
Signal Transduction and Targeted Therapy|February 11, 2025
Lactate and lactylation in cancerJie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy|February 9, 2025
AXL signaling in cancer: from molecular insights to targeted therapiesMonika Yadav, Akansha Sharma, Ketki Patne, et al.
Signal Transduction and Targeted Therapy|December 12, 2023
Therapeutic cancer vaccines: advancements, challenges, and prospectsTing Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy|December 12, 2023
Elevated peripheral levels of receptor-interacting protein kinase 1 (RIPK1) and IL-8 as biomarkers of human amyotrophic lateral sclerosisJun Wei, Min Li, Zhi Ye, et al.
Signal Transduction and Targeted Therapy|December 10, 2023
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseasesYumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy|December 6, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II studySi-Yang Liu, Song Dong, Xue-Ning Yang, et al.
Pageof 183